Results for tag: "Biliary Atresia Drug"

Biliary Atresia is a rare, life-threatening liver disease that affects infants. It is caused by a blockage in the bile ducts, which can lead to liver damage and cirrhosis. Treatment for Biliary Atresia includes surgery to remove the blockage, as well as medications to reduce inflammation and improve liver function. Liver and Kidney Disorders Drugs are used to treat a variety of conditions, including Biliary Atresia. These drugs can help reduce inflammation, improve liver function, and reduce the risk of complications. The Biliary Atresia Drug market is a rapidly growing segment of the Liver and Kidney Disorders Drugs market. Companies in this market are focused on developing new treatments and therapies to improve the quality of life for patients with Biliary Atresia. These companies are also researching new ways to diagnose and treat the condition. Some companies in the Biliary Atresia Drug market include AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck, and Pfizer. Show Less Read more